Deep learning applications in translational bioinformatics.

Deep Learning Applications in Translational Bioinformatics, a new volume in the Advances in Ubiquitous Sensing Application for Healthcare series, offers a detailed overview of basic bioinformatics, deep learning, various applications of deep learning in translational bioinformatics including deep le...

Full description

Bibliographic Details
Corporate Author: ScienceDirect (Online service)
Format: eBook
Language:English
Published: New York, NY : Academic Press, 2024.
Subjects:
Online Access:Connect to the full text of this electronic book
Table of Contents:
  • Front Cover
  • Deep Learning Applications in Translational Bioinformatics
  • Copyright Page
  • Contents
  • List of contributors
  • About the editors
  • 1 Deep learning ensembles in translational bioinformatics
  • 1.1 Introduction
  • 1.2 Basic ensembling methods
  • 1.3 Application
  • 1.3.1 Application of ensemble techniques to proteomics using microarray and mass spectrometry
  • 1.3.2 Gene-gene interaction detection using random forest
  • 1.3.3 Prediction of regulatory elements using ensemble methods
  • 1.3.3.1 Further growing uses for ensemble methods in bioinformatics
  • 1.4 Extensions of the ensemble method in bioinformatics
  • 1.5 Ensemble theory's application to feature selection
  • 1.6 Ensemble feature selection methods and stability of feature selection algorithms in bioinformatics
  • 1.6.1 Stability and feature selection algorithms
  • 1.7 Algorithmic ensembles for feature selection
  • 1.8 Conclusion
  • References
  • 2 Recursive feature elimination and multisupport vector machine in healthcare analytics
  • 2.1 Introduction
  • 2.1.1 Motivation of the work
  • 2.1.2 Contribution of the research work
  • 2.1.3 Chapter organization
  • 2.2 Related works
  • 2.2.1 Limitation of the existing works
  • 2.3 Proposed system
  • 2.3.1 Description of dataset
  • 2.3.2 Dimensionality reduction and feature selection methods in medical disease diagnosis
  • 2.3.2.1 Filtering techniques
  • 2.3.2.2 Wrapper techniques
  • 2.3.2.3 Recursive feature elimination
  • 2.3.3 Classification using multisupport vector machine
  • 2.4 Results and discussion
  • 2.4.1 Performance used in medical disease classification
  • 2.4.2 Results evaluation for recursive feature elimination calculation
  • 2.5 Conclusion
  • References
  • 3 Sensor-enabled biomedical decision support system using deep learning and fuzzy logic
  • 3.1 Introduction
  • 3.1.1 Background and motivation.
  • 3.1.2 Research problem statement
  • 3.1.3 Objectives and contributions
  • 3.1.4 Chapter organization
  • 3.2 Literature review
  • 3.2.1 Fuzzy logic
  • 3.2.1.1 Fuzzy sets and fuzzy numbers
  • 3.2.1.2 Concepts of fuzzy logic approach for research study
  • 3.2.1.3 Definition of fuzzy sets along with membership function
  • 3.2.2 The deep learning concept
  • 3.2.2.1 Convolutional neural network
  • 3.2.2.2 The concept of recurrent neural networks
  • 3.2.3 Biomedical decision support system
  • 3.2.3.1 Electronic health records
  • 3.2.3.2 The key challenges in developing biomedical decision support system
  • 3.2.4 Related work on the integration of fuzzy logic and deep learning for sensor-enabled biomedical decision support systems
  • 3.3 Methodology
  • 3.3.1 Data collection and preprocessing
  • 3.3.2 Fuzzy logic-based feature selection
  • 3.3.3 Deep learning model design and implementation
  • 3.3.4 Performance evaluation metrics
  • 3.4 Results from experiment
  • 3.4.1 Dataset description
  • 3.4.2 Performance comparison with traditional machine learning methods
  • 3.4.3 Case study: prediction of cardiovascular diseases
  • 3.4.3.1 Fuzzy logic-based feature selection
  • 3.4.3.2 Deep learning
  • 3.4.4 Case study: prediction of cardiovascular diseases using fuzzy logic and deep learning
  • 3.4.4.1 Dataset description
  • 3.4.4.2 Fuzzy logic-based feature selection
  • 3.4.4.3 Deep learning model design and implementation
  • 3.4.4.4 Performance evaluation metrics
  • 3.4.4.5 Results
  • 3.5 Discussion
  • 3.5.1 Interpretation of results
  • 3.5.2 Limitations and challenges
  • 3.5.2.1 Limitations
  • 3.5.2.2 Challenges
  • 3.5.3 Future research directions
  • 3.6 Conclusion
  • References
  • Further reading
  • 4 Prediction of Alzheimer's disease using densely convolutional neural network
  • 4.1 Introduction
  • 4.2 Literature review
  • 4.3 Methodology.
  • 4.4 Materials and tools
  • 4.4.1 Dataset
  • 4.4.2 Data preprocessing
  • 4.4.3 Dense convolutional neural network architecture
  • 4.4.4 Hyperparameters
  • 4.4.5 Evaluation
  • 4.5 Results and discussion
  • 4.6 Conclusion
  • References
  • 5 Brain tumor detection from magnetic resonance imaging images using shallow convolutional neural network
  • 5.1 Introduction
  • 5.2 Related works
  • 5.3 Methodology
  • 5.3.1 Convolutional neural network models
  • 5.3.2 Proposed shallow convolutional neural network
  • 5.3.2.1 The architecture
  • 5.3.3 Transfer learning
  • 5.3.4 Support vector machine
  • 5.4 Result and discussion
  • 5.5 Conclusion
  • References
  • 6 Multiview learning with shallow 1D-CNN for anticancer activity classification of therapeutic peptides
  • 6.1 Introduction
  • 6.2 Related work
  • 6.3 Methodology
  • 6.3.1 Convolutional neural network
  • 6.3.2 The proposed 1D-convolutional neural network
  • 6.3.3 Feature descriptor
  • 6.3.4 Sequence-based
  • 6.3.5 Standard physicochemical properties
  • 6.3.6 Physicochemical properties and sequence composition
  • 6.4 Experimental setup
  • 6.4.1 Dataset
  • 6.4.2 Result discussion
  • 6.4.3 Analysis of the optimal multiview learning
  • 6.5 Conclusion
  • References
  • 7 Deep learning methods for protein classification
  • 7.1 Introduction
  • 7.2 Literature survey
  • 7.3 Protein representation methods
  • 7.3.1 Amino-acid sequence
  • 7.3.2 Substitution matrix representation
  • 7.3.3 Physicochemical property response matrix
  • 7.4 Proposed methodology
  • 7.4.1 Dataset
  • 7.4.2 Proposed classification model
  • 7.4.2.1 Convolutional neural network
  • 7.4.2.1.1 Input layers for 2-D CNN model
  • 7.4.2.1.2 Hidden layers
  • 7.4.2.1.3 Output layers
  • 7.5 Result and discussion
  • 7.5.1 Performace evaluation metrics
  • 7.5.1.1 Accuracy
  • 7.5.1.2 Precision
  • 7.5.1.3 Recall.
  • 7.5.2 Prediction of hemolytic and nonhemolytic activity
  • 7.6 Conclusion
  • References
  • 8 Biosensors-based identification of antibiotic resistance in bacteria
  • 8.1 Introduction
  • 8.2 Gonnococal antibiotic resistance
  • 8.2.1 Penicillin
  • 8.2.2 Tetracycline
  • 8.2.3 Ciprofloxacin
  • 8.2.4 Cefixime
  • 8.2.5 Ceftriaxone
  • 8.2.6 Azithromycin
  • 8.3 Proposed work
  • 8.4 Experimentation
  • 8.5 Results and discussion
  • 8.5.1 Learning curve
  • 8.6 Conclusion
  • References
  • 9 Deep learning for vehement gene expression exploration
  • 9.1 Introduction
  • 9.2 Gene expression
  • 9.3 Gene expression analysis
  • 9.4 Gene expression functioning
  • 9.5 Gene expression technologies
  • 9.6 Microarray technique
  • 9.7 Strengths and limitations of microarray
  • 9.8 Strengths of microarrays
  • 9.9 Limitations of microarrays
  • 9.10 Microarray functioning
  • 9.11 RNA-Seq technique
  • 9.12 Strengths and limitations of RNA-Seq
  • 9.13 Strengths of RNA-seq
  • 9.14 Limitations of RNA-seq
  • 9.15 RNA-Seq functioning
  • 9.16 Study on RNA-Seq over microarray
  • 9.17 Deep learning
  • 9.18 Deep learning sets unique from neural network
  • 9.19 Deep learning sets unique from machine learning
  • 9.20 Deep learning architectures: convolutional neural network and recurrent neural network
  • 9.21 Convolutional neural network functioning
  • 9.22 Recurrent neural networks functioning
  • 9.23 Deep learning for gene expression
  • 9.24 Convolutional neural networks for gene expression
  • 9.25 Recurrent neural network for gene expression
  • 9.26 Potential of recurrent neural network over convolutional neural network for gene expression
  • 9.27 Conclusion
  • References
  • 10 Machine learning-enforced bioinformatics approaches for drug discovery and development
  • 10.1 Introduction
  • 10.2 Drug discovery: an introduction and historical perspective
  • 10.3 Machine learning approaches.
  • 10.4 Machine learning-enforced bioinformatic tools for drug discovery
  • 10.4.1 Random forest
  • 10.4.2 Artificial neural network-based approaches
  • 10.4.2.1 Convolutional neural networks
  • 10.4.2.2 Support vector machines
  • 10.4.2.3 Multilayer perception neural network
  • 10.4.2.4 Recurrent neural networks
  • 10.4.3 Bayesian models
  • 10.5 Deep machine learning
  • 10.6 Artificial intelligence
  • 10.7 Machine learning-, deep learning-, and artificial intelligence-enforced bioinformatics and cheminformatics tools
  • 10.7.1 Drug design, drug prediction, and optimization
  • 10.7.2 Determination of the target and validation
  • 10.7.3 Prophecy of drug-drug interaction
  • 10.7.4 Compound screening or hit discovery
  • 10.7.5 Drug repurposing
  • 10.7.6 Molecular docking
  • 10.7.7 Drug safety assessment
  • 10.8 Challenges and opportunities
  • 10.9 Conclusion
  • References
  • 11 Role of deep learning in predicting drug formulations and delivery systems
  • 11.1 Introduction
  • 11.2 Databases, deep learning tools and techniques
  • 11.2.1 Establishing the dataset
  • 11.2.2 Deep learning tools and techniques
  • 11.3 Data processing methods
  • 11.3.1 Steps involved in data preprocessing
  • 11.4 Artificial intelligence algorithms and models in dosage form development
  • 11.4.1 Application of artificial intelligence in pharmaceutical drug formulations
  • 11.5 Conclusions and future prospects
  • References
  • 12 Deep learning in computer-aided drug design: a case study
  • 12.1 Introduction
  • 12.1.1 Drug designing approaches
  • 12.1.1.1 Structure-based drug design
  • 12.1.1.2 Ligand-based drug design
  • 12.1.2 Why deep learning in computer-aided drug design?
  • 12.2 Role of deep learning in computer-aided drug design
  • 12.3 Software tools, web servers, and package
  • 12.3.1 Parameters
  • 12.3.2 Tools
  • 12.3.3 Packages.